02/10/2025
5:25 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
4:40 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
5:00 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
4:21 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/07/2025
3:29 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:29 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:30 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:30 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
11:15 PM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form EFFECT | |
01/14/2025
5:22 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-1/A | |
01/13/2025
6:00 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for PVLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/08/2025
2:04 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/31/2024
5:04 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/20/2024
4:32 PM | Kaupinen Wes (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/20/2024
3:56 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
12/20/2024
3:59 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13G | |
12/19/2024
9:23 AM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:45 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:46 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:40 PM | KIRITSY CHRISTOPHER P (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:41 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:42 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:44 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:44 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:42 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
12/17/2024
4:44 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:22 PM | Dellora Investments LP (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
6:40 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:42 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
3:18 PM | Dellora Investments LP (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:53 PM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again? Click here for his emergency broadcast... |
12/12/2024
3:16 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:32 AM | KIRITSY CHRISTOPHER P (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
1:21 PM | Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/18/2024
3:16 PM | Dellora Investments LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2024
8:07 AM | Lynx1 Capital Management LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:02 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:01 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/07/2024
7:47 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
11/06/2024
4:00 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form ARS | |
11/06/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form DEF 14A | |
11/05/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/29/2024
7:45 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/28/2024
4:18 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/15/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/15/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
09/23/2024
5:15 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
08/12/2024
5:48 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:29 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/07/2024
1:16 PM | Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G | |
08/01/2024
7:00 AM | ADAR1 Capital Management, LLC (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G | |
07/31/2024
6:26 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2024
5:40 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
5:40 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
07/03/2024
3:32 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:21 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:31 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
